contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


episurf-medical-enters-into-distribution-agreement-for-several-european-countries-with-joint-operations-ltd

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.

Episurf Medical

Episurf Medical (Nasdaq: EPIS B) today announces that it has entered into a distribution agreement with Joint Operations Ltd for several European countries. Initially targeted countries include...

Episurf Medical (Nasdaq: EPIS B) today announces that it has entered into a distribution agreement with Joint Operations Ltd for several European countries. Initially targeted countries include Germany, UK, Ireland and Austria, with the possibility to add additional countries going forward. By the agreement, Episurf Medical will significantly expand the reach of its sales force in the selected markets, while also benefiting from Joint Operations' experience within joint reconstruction and small implants.&nbsp;&nbsp;"I am pleased with announcing our co-operation with Joint Operations which covers Europe's most important markets from day one, with the opportunity to add additional countries going forward. Joint Operations has excellent reach within their organisation and within their network, and they have significant experience from the joint reconstruction and small implant field. For Episurf, this means that we have one key partner for a big part of Europe, including a reduction in our general overhead and marketing expenses, which very well matches our overall strategy of optimising our organisation and working with strong distributors and distribution partners globally. We are very impressed with the company that Richard Forster and his team have built, and we look forward to the next steps together", says Pål Ryfors, CEO Episurf Medical.&nbsp;&nbsp;Joint Operations is a UK based distributor of products and solutions for joint preservation and extremities. The group has extensive experience within its targeted market segments, and the group has either direct or indirect representation in several markets in Europe, the Middle East, Africa and the US. In Germany, Joint Operations is active through its subsidiary 2med GmbH, which was acquired in 2020.&nbsp;&nbsp;&nbsp;"Our strategy is to interrupt the road toward arthroplasty and revision arthroplasty by managing arthritic progression at an earlier stage, and we believe that Episurf is a perfect partner for us, as their products fit extremely well into our strategy. We are very impressed with the clinical foundation that the company relies upon, and in our opinion, the Episealer® technology represents what many surgeons increasingly are asking for today", says Richard Forster, Managing Director and Co-founder, Joint Operations.&nbsp;&nbsp;The co-operation will come into force during the second quarter of 2025.<div></div>

Episurf Medical enters into distribution agreement for several European countries with Joint Operations Ltd

Probabilities of success in drug development

Return on capital (ROE, ROI, ROIC, RONIC)

Valuation methods: DCF model

Valuation methods: Valuation multiples

What a stock picker should understand about the new mandatory corporate sustainability (CSRD) reports, part 1.